Related references
Note: Only part of the references are listed.Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Fernanda G. Herrera et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib
Aiste McCormick et al.
CLINICAL CANCER RESEARCH (2017)
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers
Kim A. Reiss et al.
GYNECOLOGIC ONCOLOGY (2017)
Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological Malignancies
Shane Mesko et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Biomarkers of Response and Resistance to DNA Repair Targeted Therapies
Elizabeth H. Stover et al.
CLINICAL CANCER RESEARCH (2016)
The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma
Liat Hogen et al.
GYNECOLOGIC ONCOLOGY (2016)
Ovarian cancer and the immune system - The role of targeted therapies
Taylor B. Turner et al.
GYNECOLOGIC ONCOLOGY (2016)
Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer
Kevin Albuquerque et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011
Sagar C. Patel et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Translation of Targeted Radiation Sensitizers into Clinical Trials
Zachery R. Reichert et al.
SEMINARS IN RADIATION ONCOLOGY (2016)
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
Shih-Hung Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
Abscopal effects of radiation therapy: A clinical review for the radiobiologist
Shankar Siva et al.
CANCER LETTERS (2015)
Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage
Yulan Cheng et al.
PLOS ONE (2015)
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
Mario Crittenden et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer Four-year outcomes
Nathalie Rochet et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2015)
Radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses - pre-clinical evidence and ongoing clinical applications
Anja Derer et al.
FRONTIERS IN IMMUNOLOGY (2015)
Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer
Charles A. Kunos et al.
FRONTIERS IN ONCOLOGY (2015)
A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis
Kim A. Reiss et al.
CLINICAL CANCER RESEARCH (2015)
Patterns of Recurrence and Role of Pelvic Radiotherapy in Ovarian Clear Cell Adenocarcinoma
Bryan D. Macrie et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Radiation Therapy for Chemotherapy-Resistant Recurrent Epithelial Ovarian Cancer
Shizuo Machida et al.
ONCOLOGY (2014)
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888
Richard Tuli et al.
TRANSLATIONAL ONCOLOGY (2014)
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer
Mariano Provencio et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2014)
Role of stereotactic radiosurgery in gynecologic cancer
Charles A. Kunos et al.
CURRENT OPINION IN ONCOLOGY (2013)
Involved-field radiation therapy for locoregionally recurrent ovarian cancer
Aaron P. Brown et al.
GYNECOLOGIC ONCOLOGY (2013)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Clear cell carcinoma of the ovary: A review of the literature
Marcela G. del Carmen et al.
GYNECOLOGIC ONCOLOGY (2012)
Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation
Paul J. Hoskins et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response
Ying-Hua Li et al.
PLOS ONE (2012)
Stereotactic Radiosurgery for Gynecologic Cancer
Charles Kunos et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Radiation-induced effects and the immune system in cancer
Punit Kaur et al.
FRONTIERS IN ONCOLOGY (2012)
Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers
K. D. Swenerton et al.
ANNALS OF ONCOLOGY (2011)
Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study
Nathalie Rochet et al.
BMC CANCER (2011)
Emerging application of stereotactic body radiation therapy for gynecologic malignancies
Nina A. Mayr et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group
Charles A. Kunos et al.
GYNECOLOGIC ONCOLOGY (2011)
Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology
Daniel S. Higginson et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Improved Classification of Epithelial Ovarian Cancer Results of 3 Danish Cohorts
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Increasing Sensitivity to Radiotherapy and Chemotherapy by Using Novel Biological Agents that Alter the Tumor Microenvironment
E. T. Shinohara et al.
CURRENT MOLECULAR MEDICINE (2009)
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective
Elke A. Jarboe et al.
HISTOPATHOLOGY (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Stereotactic radiotherapy in recurrent gynecological cancer: A case series
Francesco Deodato et al.
ONCOLOGY REPORTS (2009)
Stereotactic Body Radiosurgery for Pelvic Relapse of Gynecologic Malignancies
Charles Kunos et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
T-cell responses to survivin in cancer patients undergoing radiation therapy
Doerthe Schaue et al.
CLINICAL CANCER RESEARCH (2008)
Helical tomotherapy as a new treatment technique for whole abdominal irradiation
Nathalie Rochet et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol
Nathalie Rochet et al.
BMC CANCER (2007)
Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary
Yutaka Nagai et al.
GYNECOLOGIC ONCOLOGY (2007)
Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: A phase I study exploring a new treatment paradigm
William F. Regine et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Standard treatments induce antigen-specific immune responses in prostate cancer
Nancy J. Nesslinger et al.
CLINICAL CANCER RESEARCH (2007)
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer
JL Gulley et al.
CLINICAL CANCER RESEARCH (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes
E Petermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer
KV Albuquerque et al.
GYNECOLOGIC ONCOLOGY (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma:: A randomized trial of the Gynecologic Oncology Group
MA Varia et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment
B Sorbe
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Adjuvant treatment for early ovarian cancer: A randomized phase III trial of intraperitoneal P-32 or intravenous cyclophosphamide and cisplatin - A gynecologic oncology group study
RC Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A phase I/II study of hypofractionated whole abdominal radiation therapy in patients with chemoresistant ovarian carcinoma: Karnofsky score determines treatment outcome
G Faul et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
